2015•Annals of the Rheumatic DiseasesRequires access

FRI0005 Combination Blocking of IL-22 and IL-17 During Experimental Arthritis Potently Reduces TH17-Driven Disease Progression

Debbie M. Roeleveld, Rebecca Rogier, Birgitte Walgreen, M.M. Helsen, Liduine van den Bersselaar, Wim B. van den Berg, Peter M. van der Kraan, Marije I. Koenders

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Arthritis, Rheumatoid arthritis, Immunology, Cytokine, Interleukin 17

Back to paper search Browse research topics Original source

FRI0005 Combination Blocking of IL-22 and IL-17 During Experimental Arthritis Potently Reduces TH17-Driven Disease Progression — Research Paper | ScholarLens